Literature DB >> 2449758

Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer.

D Mannini1, P Maver, E Aiello, G Corrado, F Vecchi, B Bellanova, M Marengo.   

Abstract

Spontaneous circadian variations of prostate specific antigen (PSA) and prostatic acid phosphatase (PAP), determined simultaneously by radioimmunoassay (RIA), were investigated by multiple sampling, over a 24-hour period, in 32 patients with prostatic cancer. In 29/32 patients (91%), the coefficient of variation of 24-hour values, for either marker, was greater than that of the RIA method at the same range of values; stage D patients showed the greatest spontaneous variability. Fluctuations around the mean of 24-hour values ranged from -65% to +85% for PAP, from -72% to +190% for PSA, occurring random and independently for each marker. Variability was about 20% greater for PSA than for PAP. The existence of spontaneous fluctuations should be considered in multiple marker evaluation of prostatic cancer patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449758     DOI: 10.1007/bf00264621

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  12 in total

1.  CIRCADIAN VARIATION OF SERUM ACID PHOSPHATASE IN PROSTATIC CANCER.

Authors:  R P DOE; G T MELLINGER
Journal:  Metabolism       Date:  1964-05       Impact factor: 8.694

2.  The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates.

Authors:  M J Warhol; J A Longtine
Journal:  J Urol       Date:  1985-09       Impact factor: 7.450

3.  EPITHELIOMA OF THE GENITO-URINARY ORGANS.

Authors:  A C Broders
Journal:  Ann Surg       Date:  1922-05       Impact factor: 12.969

4.  Human prostate-specific antigen: structural and functional similarity with serine proteases.

Authors:  K W Watt; P J Lee; T M'Timkulu; W P Chan; R Loor
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 5.  Natural history and staging of prostate cancer.

Authors:  W F Whitmore
Journal:  Urol Clin North Am       Date:  1984-05       Impact factor: 2.241

6.  The role of serum prostatic acid phosphatase as a tumor marker in men with advanced adenocarcinoma of the prostate.

Authors:  T J Maatman; M K Gupta; J E Montie
Journal:  J Urol       Date:  1984-07       Impact factor: 7.450

7.  Acute and chronic retention of urine: relevance of raised serum prostatic acid phosphatase levels. A prospective study.

Authors:  D S Collier; J A Pain
Journal:  Urology       Date:  1986-01       Impact factor: 2.649

8.  Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.

Authors:  M Kuriyama; M C Wang; C L Lee; C S Killian; L D Papsidero; H Inaji; R M Loor; M F Lin; T Nishiura; N H Slack; G P Murphy; T M Chu
Journal:  J Natl Cancer Inst       Date:  1982-01       Impact factor: 13.506

9.  Circadian and day-to-day variation of prostatic acid phosphatase.

Authors:  I Nissenkorn; D D Mickey; D B Miller; M S Soloway
Journal:  J Urol       Date:  1982-06       Impact factor: 7.450

10.  Elevation of serum prostatic acid phosphatase levels after prostatic massage.

Authors:  J Wadström; P Huber; G Rutishauser
Journal:  Urology       Date:  1984-12       Impact factor: 2.649

View more
  3 in total

1.  Daily variability of serum prostate-specific antigen in men over 50 years of age.

Authors:  A Tekin; N Atsu; H Ozen
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Hospitalization decreases serum prostate-specific antigen values compared with outpatient values in patients with benign prostatic diseases.

Authors:  In Seok Yoon; Tae Young Shin; Sun Il Kim; Seong Kon Park; Hyun Ik Jang; Jong Bo Choi; Hyun Soo Ahn; Young Soo Kim; Se Joong Kim
Journal:  Korean J Urol       Date:  2013-09-10

3.  A population study of fasting time and serum prostate-specific antigen (PSA) level.

Authors:  Cheryl K Lau; Maggie Guo; Jeannine A Viczko; Christopher T Naugler
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.